Results 191 to 200 of about 38,496 (259)

Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibition. [PDF]

Clin Epigenetics
Bertoldi M, Albamonte E, Bello L, D'amico A, Masson R, Nigro V, Pane M, Panicucci C, Sframeli M, Ricci F.   +9 more
europepmc   +1 more source

Short-term daily deflazacort decreases membrane permeability and increases maximum force in <i>mdx</i> mice. [PDF]

Am J Physiol Cell Physiol
Turner KD, Qian Y, Claflin DR, Newell-Stamper BL, Peter AK, Michele DE, Russell AJ, Brooks SV.   +7 more
europepmc   +1 more source

Dystrophin Restorative and Compensatory Gene Addition Therapies for Duchenne Muscular Dystrophy: Could CRISPRa Provide a Realistic Alternative? [PDF]

Muscles
Rostamitehrani Z, Javed R, Popplewell L.
europepmc   +1 more source

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor. [PDF]

Endocr Metab Sci
Lowe J, Piepho AB, Gomatam CK, Debell P, Ballinger MN, Rafael-Fortney JA.   +5 more
europepmc   +1 more source

Monoclonal Antibody MDX-220 [PDF]

, 2020
openaire   +1 more source

Tauroursodeoxycholic acid-induced increase in ectopic muscle mineralization occurs exclusively in dystrophic muscles and is independent of endoplasmic reticulum stress. [PDF]

Sci Rep
Róg J, Dymkowska D, Michalska B, Krupska O, Milewski K, Matryba P, Wolny A, Pawłowska M, Bożycki Ł, Stępnik D, Górecki DC, Zabłocki K.   +11 more
europepmc   +1 more source

Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy

Disease Models & Mechanisms
Conner C. Earl, Areli J. Javier, Alyssa M. Richards, Larry W. Markham, Craig J. Goergen, Steven S. Welc   +5 more
doaj   +1 more source

A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health. [PDF]

Mol Ther Nucleic Acids
Moon YJ, Hindupur R, Gamu IH, McCormack NM, Shaikh F, Novak JS, Jaiswal JK.   +6 more
europepmc   +1 more source

MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration. [PDF]

EMBO Mol Med
Sowa N, Horie T, Ide Y, Baba O, Kora K, Yoshida T, Nakamura Y, Matsumura S, Matsushita K, Imanaka M, Zou F, Kume E, Kojima H, Qian Q, Kimura K, Otsuka R, Hara N, Yamasaki T, Otani C, Tsujisaka Y, Takaya T, Nishimura C, Watanabe D, Hasegawa K, Kotera J, Oka K, Fujita R, Takemiya A, Sasaki T, Kasahara Y, Obika S, Kimura T, Ono K.   +32 more
europepmc   +1 more source

Differential Expression of Utrophin‐A and ‐B Promoters in the Central Nervous System (CNS) of Normal and Dystrophic mdx Mice

, 2009
Santhosh M. Baby, Sasha Bogdanovich, Gabriel Willmann, Utpal Basu, Olga Lozynska, Tejvir S. Khurana   +5 more
openalex   +2 more sources